Faron Pharmaceuticals Oy (LON:FARN) Share Price Passes Below 50 Day Moving Average – Here’s Why

Faron Pharmaceuticals Oy (LON:FARN)’s stock price passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 171.53 ($2.15) and traded as low as GBX 167.70 ($2.10). Faron Pharmaceuticals Oy shares last traded at GBX 167.80 ($2.10), with a volume of 3,575 shares changing hands.

Faron Pharmaceuticals Oy Stock Down 1.4 %

The company has a market cap of £175.45 million, a P/E ratio of -524.06 and a beta of 0.36. The company’s 50-day moving average is GBX 171.53 and its two-hundred day moving average is GBX 167.15. The company has a debt-to-equity ratio of 922.55, a current ratio of 1.45 and a quick ratio of 1.09.

Faron Pharmaceuticals Oy Company Profile

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.